FindTrial
Sign In

E7050

DRUG6 trials

Sponsors

Eisai Inc., Eisai Co., Ltd., Eisai Limited

Conditions

Advanced or Metastatic Solid TumorsCancerGastric CancerHealthy SubjectsPlatinum-Resistant Squamous Cell Carcinoma of the Head and NeckPreviously Untreated Gastric CancerSolid TumorSolid Tumors

Phase 1

A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors
CompletedNCT00869895
Eisai Inc.Cancer
Start: 2009-03-31Updated: 2016-01-29
A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors
CompletedNCT00921869
Eisai Co., Ltd.Solid Tumors
Start: 2009-10-31End: 2011-06-30Updated: 2017-12-26
E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
CompletedNCT01332266
Eisai Inc.Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Start: 2011-09-19End: 2017-09-04Updated: 2022-01-03
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
TerminatedNCT01355302
Eisai Inc.Advanced or Metastatic Solid Tumors, Previously Untreated Gastric Cancer
Start: 2011-11-30End: 2013-07-31Updated: 2017-05-15
A Phase I Study of E7050 in Subjects With Solid Tumors
CompletedNCT01428141
Eisai Co., Ltd.Gastric Cancer, Solid Tumor
Start: 2011-09-30End: 2013-07-31Updated: 2014-02-14
Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers
CompletedNCT02533102
Eisai LimitedHealthy Subjects
Start: 2010-11-30End: 2011-02-28Updated: 2015-11-20